Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret von Mehren

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
The Lancet. Oncology|July 7, 2007
Trabectedin--a targeted chemotherapy?Margaret von Mehren
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Role of new chemotherapy agents in soft tissue sarcomaMargaret von Mehren
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2004
Targeted therapy with imatinib: hits and misses?Margaret von Mehren
Current Opinion in Oncology|June 6, 2008
The role of adjuvant and neoadjuvant therapy in gastrointestinal stromal tumorsMargaret von Mehren
Current Oncology Reports|April 19, 2006
Imatinib-refractory gastrointestinal stromal tumors: the clinical problem and therapeutic strategiesMargaret von Mehren
The Surgical Clinics of North America|August 21, 2016
Management of Gastrointestinal Stromal TumorsMargaret von Mehren
Oncology (Williston Park, N.Y.)|June 21, 2019
Honing in on Subtypes to Guide More Individualized Treatment of Soft Tissue SarcomaMargaret Von Mehren
Current Treatment Options in Oncology|October 31, 2003
New therapeutic strategies for soft tissue sarcomasMargaret von Mehren
Seminars in Oncology|February 24, 2005
Colorectal cancer vaccines: what we know and what we don't yet knowMargaret von Mehren
Oncology (Williston Park, N.Y.)|February 23, 2007
New therapeutics for soft-tissue sarcomas in adultsMargaret von Mehren
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
The Lancet. Oncology|July 7, 2007
Trabectedin--a targeted chemotherapy?Margaret von Mehren
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Role of new chemotherapy agents in soft tissue sarcomaMargaret von Mehren
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2004
Targeted therapy with imatinib: hits and misses?Margaret von Mehren
Current Opinion in Oncology|June 6, 2008
The role of adjuvant and neoadjuvant therapy in gastrointestinal stromal tumorsMargaret von Mehren
Current Oncology Reports|April 19, 2006
Imatinib-refractory gastrointestinal stromal tumors: the clinical problem and therapeutic strategiesMargaret von Mehren
The Surgical Clinics of North America|August 21, 2016
Management of Gastrointestinal Stromal TumorsMargaret von Mehren
Oncology (Williston Park, N.Y.)|June 21, 2019
Honing in on Subtypes to Guide More Individualized Treatment of Soft Tissue SarcomaMargaret Von Mehren
Current Treatment Options in Oncology|October 31, 2003
New therapeutic strategies for soft tissue sarcomasMargaret von Mehren
Seminars in Oncology|February 24, 2005
Colorectal cancer vaccines: what we know and what we don't yet knowMargaret von Mehren
Oncology (Williston Park, N.Y.)|February 23, 2007
New therapeutics for soft-tissue sarcomas in adultsMargaret von Mehren
Pageof 20